News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
AstraZeneca PLC Drug Recommended in EU for Some Depression
April 23, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- AstraZeneca's (AZN.L) schizophrenia drug Seroquel XR has been recommended by European regulators as an add-on treatment for depression, following an earlier rebuff in the Netherlands.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Regulatory
Europe
AstraZeneca Pharmaceuticals LP
MORE ON THIS TOPIC
Insights
JPM26: As Capital Concentrates, VCs Scrutinize Founder Pedigree and CEO Fit in Early Biotech
January 15, 2026
·
2 min read
·
Jennifer Smith-Parker
Job Trends
3 Top Challenges Facing Manufacturing Professionals Right Now
January 15, 2026
·
6 min read
·
Angela Gabriel
Opinion
Trump Must Make Biotech Innovation a National Priority
January 14, 2026
·
7 min read
·
Cyriac Roeding
Business
JPM26: Lilly Plots Path to Dominance as Obesity Market Enters a New Era
January 14, 2026
·
2 min read
·
Nick Paul Taylor
